Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Antiarthritic MMP inhibitor described by Chugai

Aug. 16, 1996

Kureha discloses MMP-inhibitory esculetin derivatives

Aug. 16, 1996

Nisshin Flour Milling describes agents for septic shock

Aug. 16, 1996

P-selectin inhibitors reported by BMS

Aug. 16, 1996

MGI Pharma issued Israeli marketing approval for Salagen line extension

Aug. 9, 1996

Palauolol: A novel antiinflammatory phospholipase A2 inhibitor

Aug. 9, 1996

Niacinamide development update

Aug. 9, 1996

Japan Tobacco describes cell adhesion inhibitors

Aug. 9, 1996

Erythropoietin claimed as chronic inflammation treatment

July 26, 1996

World's first clinical trial on gene therapy for arthritis underway

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 4, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
Checkpoint inhibitor journey traces Chinese firms’ path to global revenue
BioWorld
Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...